Tenax Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$8.54 |
Market Cap |
$8.48 M |
Shares Outstanding |
6.19 M |
Public Float |
1.16 M |
Address |
ONE Copley Parkway Morrisville North Carolina 27560 United States |
Employees | - |
Website | http://www.tenaxthera.com |
Updated | 07/08/2019 |
Tenax Therapeutics, Inc. is a pharmaceutical company, which focuses on identifying, developing, and commercializing novel therapeutic products for the critical care market. Its product candidate includes Levosimendan, a calcium sensitizer activator for intravenous use in hospitalized patients with acutely decompensated heart failure. The company was founded on May 26, 1967 and is headquartered in Morrisville, NC. |